In the News

Capital Markets, WallachBeth Capital / March 18, 2024

Wallachbeth Capital is Pleased to Announce the Closing of bioAffinity Technologies $2.5 Million Registered Direct Offering and Concurrent Private Placement.

WallachBeth Capital LLC, a leading provider of capital markets and institutional execution services, announced today that 60 Degrees Pharmaceuticals, Inc., …

ETFs, WallachBeth Capital / March 14, 2024

2024 WallachBeth Symposium, Park City, UT

Last week, industry leaders and friends gathered in Park City for the highly anticipated 2024 WallachBeth Symposium! Attendees fostered valuable connections, …

Uncategorized / December 12, 2023

Andy McOrmond, Managing Director ETF Trading, joined Bob Pisani on ETF Edge yesterday to recap 2023 and discuss outlook for 2024 alongside BNY Mellon’s Ben …

[Read more...] about

https://wallachbeth.com/2678-2/

« Previous Page

Wallachbeth Capital is Pleased to Announce the Closing of bioAffinity Technologies $2.5 Million Registered Direct Offering and Concurrent Private Placement.

2024 WallachBeth Symposium, Park City, UT

Contact Us

About Us

In the News

Footer

Contact Us

About Us

Follow Us